Financial Wealth Daily

US FDA approves Gilead’s twice-yearly injection for HIV prevention

By Deena Beasley and Julie Steenhuysen (Reuters) -The U.S. Food and Drug Administration on Wednesday approved Gilead Sciences lenacapavir, a twice-yearly injection, for preventing HIV infection in adults and adolescents. Gilead said the drug will be sold under the brand name Yeztugo. Investors and AIDS activists had been eagerly awaiting the regulatory decision for a…

Read More

Forecaster says US House version of Trump bill to cost $2.8 trillion despite economic gains

Here’s the Best Day to Buy Nvidia   Strange picture predicts the market’s next move? [sponsor] [adv] Here’s the Best Day to Buy Nvidia [sponsor] Did you know Nvidia has an 86% history of soaring, beginning on one particular day every single spring? We call this the “Green Day phenomenon.” It works on 5,000 stocks. For example,…

Read More

Trump contradicts his spy chief on Iran’s nuclear program

By Jonathan Landay WASHINGTON (Reuters) -U.S. President Donald Trump on Tuesday repudiated Director of National Intelligence Tulsi Gabbard’s assessment that Iran has not been building a nuclear weapon, publicly contradicting his spy chief for the first time during his second term. In rejecting his top spy’s judgment, Trump appeared to embrace Israeli Prime Minister Benjamin…

Read More

    Forecaster says US House version of Trump bill to cost $2.8 trillion despite economic gains

    By David Morgan WASHINGTON (Reuters) -President Donald Trump’s sweeping tax-cut and spending bill would lead to a larger-than-expected $2.8 trillion increase in the federal deficit over the decade, despite a boost to U.S. economic output, the nonpartisan Congressional Budget Office projected on Tuesday. The budget watchdog’s dynamic analysis of the legislation, which passed the House…

    Read More